Journal Home
Search for

Volume 17, Issue 5, Pages 395-403 (October 2008)


View previous. 11 of 30 View next.

Mesenchymal Stem Cells: Isolation, Characterisation and In Vivo Fluorescent Dye Tracking

Christopher Weir, PhDabd, Marie-Christine Morel-Kopp, PhDbd, Anthony Gill, FRCPAcd, Kellie Tinworth, MScad, Leigh Ladd, PhDad, Stephen N. Hunyor, MDadCorresponding Author Informationemail address, Christopher Ward, PhDbd

Received 13 December 2007; received in revised form 15 January 2008; accepted 20 January 2008.

Cell therapies have been used to regenerate the heart by direct myocardial delivery, by coronary infusion and by surface attached scaffolds. Multipotent mesenchymal stem cells (MSC) with capacity to differentiate into cardiomyocytes and other cell lines have been predominantly trialled in rodents. However, large animal models are increasingly needed to translate basic research into new, safe regenerative therapies. Understanding the mode of action of cell therapies in the mammalian heart has been limited by cell tracking capability. This study examined the ability to track the fate of allogeneic MSC in sheep using various fluorescent dyes.

MSC isolated from sheep bone marrow were grown in culture following extraction and flow cytometric characterisation. After labelling with fluorescent tracking dyes (e.g. CFSE and DiI) cells were tested for in vitro and in vivo signal up to six weeks. Labelling effect on cell division and differentiation was studied.

Several dyes lost fluorescence and slowed cell division. However, the thiol reactive dye CM-DiI showed detectable in vivo fluorescence in labelled MSC six weeks after injection into sheep skeletal muscle and two weeks after implantation of an MSC coated biomaterial scaffold. CM-DiI labelled MSC differentiated in vitro showed label retention over four weeks.

The fluorescent membrane dye CM-DiI tracks implanted sheep MSC and provides an alternative to traditional cell markers such as gene modified GFP.

a Cardiac Technology Centre & Kolling Institute, Sydney, Australia

b Northern Blood Research Centre and Department of Haematology, Sydney, Australia

c Anatomical Pathology Department, Sydney, Australia

d University of Sydney at Royal North Shore Hospital, Sydney, Australia

Corresponding Author InformationCorresponding author at: Cardiac Technology Centre, Department of Cardiology, Royal North Shore Hospital, St Leonards, Sydney, NSW 2065, Australia. Tel.: +61 2 9926 8679; fax: +61 2 9901 4097.

PII: S1443-9506(08)00010-3

doi:10.1016/j.hlc.2008.01.006


View previous. 11 of 30 View next.